nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A3—Metformin—metabolic syndrome X	0.37	0.475	CbGbCtD
Procainamide—SLC22A2—Metformin—metabolic syndrome X	0.219	0.281	CbGbCtD
Procainamide—SLC22A1—Metformin—metabolic syndrome X	0.19	0.244	CbGbCtD
Procainamide—Function kidney decreased—Metformin—metabolic syndrome X	0.019	0.228	CcSEcCtD
Procainamide—Gastrointestinal tract irritation—Metformin—metabolic syndrome X	0.0116	0.139	CcSEcCtD
Procainamide—Lightheadedness—Metformin—metabolic syndrome X	0.00371	0.0446	CcSEcCtD
Procainamide—Renal impairment—Metformin—metabolic syndrome X	0.00316	0.038	CcSEcCtD
Procainamide—Lethargy—Metformin—metabolic syndrome X	0.00307	0.0369	CcSEcCtD
Procainamide—Abdominal pain upper—Metformin—metabolic syndrome X	0.00275	0.033	CcSEcCtD
Procainamide—Abdominal discomfort—Metformin—metabolic syndrome X	0.00249	0.03	CcSEcCtD
Procainamide—SCN7A—cardiovascular system—metabolic syndrome X	0.00246	0.0714	CbGeAlD
Procainamide—Neutropenia—Metformin—metabolic syndrome X	0.00243	0.0292	CcSEcCtD
Procainamide—SCN7A—adipose tissue—metabolic syndrome X	0.00217	0.0629	CbGeAlD
Procainamide—Bradycardia—Metformin—metabolic syndrome X	0.00212	0.0255	CcSEcCtD
Procainamide—Cardiac disorder—Metformin—metabolic syndrome X	0.00193	0.0232	CcSEcCtD
Procainamide—Flushing—Metformin—metabolic syndrome X	0.00193	0.0232	CcSEcCtD
Procainamide—DNMT1—cardiovascular system—metabolic syndrome X	0.00189	0.0548	CbGeAlD
Procainamide—Chills—Metformin—metabolic syndrome X	0.00187	0.0224	CcSEcCtD
Procainamide—Dysgeusia—Metformin—metabolic syndrome X	0.00177	0.0213	CcSEcCtD
Procainamide—SCN9A—adipose tissue—metabolic syndrome X	0.0017	0.0493	CbGeAlD
Procainamide—SCN4A—kidney—metabolic syndrome X	0.00168	0.0488	CbGeAlD
Procainamide—Ill-defined disorder—Metformin—metabolic syndrome X	0.00168	0.0202	CcSEcCtD
Procainamide—DNMT1—adipose tissue—metabolic syndrome X	0.00167	0.0484	CbGeAlD
Procainamide—Malaise—Metformin—metabolic syndrome X	0.00163	0.0196	CcSEcCtD
Procainamide—SLC22A2—kidney—metabolic syndrome X	0.00155	0.0448	CbGeAlD
Procainamide—Myalgia—Metformin—metabolic syndrome X	0.00154	0.0185	CcSEcCtD
Procainamide—SCN7A—liver—metabolic syndrome X	0.00152	0.0441	CbGeAlD
Procainamide—Discomfort—Metformin—metabolic syndrome X	0.00152	0.0183	CcSEcCtD
Procainamide—SCN4A—adipose tissue—metabolic syndrome X	0.00152	0.044	CbGeAlD
Procainamide—Shock—Metformin—metabolic syndrome X	0.00145	0.0175	CcSEcCtD
Procainamide—Thrombocytopenia—Metformin—metabolic syndrome X	0.00145	0.0174	CcSEcCtD
Procainamide—Anorexia—Metformin—metabolic syndrome X	0.00141	0.0169	CcSEcCtD
Procainamide—Hypotension—Metformin—metabolic syndrome X	0.00138	0.0166	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00135	0.0162	CcSEcCtD
Procainamide—SCN5A—cardiovascular system—metabolic syndrome X	0.00133	0.0387	CbGeAlD
Procainamide—SCN3A—kidney—metabolic syndrome X	0.00131	0.038	CbGeAlD
Procainamide—Decreased appetite—Metformin—metabolic syndrome X	0.00128	0.0154	CcSEcCtD
Procainamide—Feeling abnormal—Metformin—metabolic syndrome X	0.00122	0.0146	CcSEcCtD
Procainamide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00121	0.0145	CcSEcCtD
Procainamide—SCN3A—adipose tissue—metabolic syndrome X	0.00118	0.0342	CbGeAlD
Procainamide—Urticaria—Metformin—metabolic syndrome X	0.00117	0.0141	CcSEcCtD
Procainamide—DNMT1—liver—metabolic syndrome X	0.00117	0.0339	CbGeAlD
Procainamide—Abdominal pain—Metformin—metabolic syndrome X	0.00117	0.014	CcSEcCtD
Procainamide—SLC22A4—kidney—metabolic syndrome X	0.00115	0.0332	CbGeAlD
Procainamide—CHRM2—cardiovascular system—metabolic syndrome X	0.00114	0.0329	CbGeAlD
Procainamide—SLC22A1—kidney—metabolic syndrome X	0.00109	0.0316	CbGeAlD
Procainamide—Asthenia—Metformin—metabolic syndrome X	0.00106	0.0127	CcSEcCtD
Procainamide—Pruritus—Metformin—metabolic syndrome X	0.00105	0.0126	CcSEcCtD
Procainamide—SLC22A3—kidney—metabolic syndrome X	0.00104	0.0302	CbGeAlD
Procainamide—SLC22A4—adipose tissue—metabolic syndrome X	0.00103	0.03	CbGeAlD
Procainamide—Diarrhoea—Metformin—metabolic syndrome X	0.00101	0.0122	CcSEcCtD
Procainamide—SLC22A1—adipose tissue—metabolic syndrome X	0.000984	0.0285	CbGeAlD
Procainamide—Dizziness—Metformin—metabolic syndrome X	0.000977	0.0118	CcSEcCtD
Procainamide—SLC22A3—adipose tissue—metabolic syndrome X	0.000941	0.0273	CbGeAlD
Procainamide—Vomiting—Metformin—metabolic syndrome X	0.000939	0.0113	CcSEcCtD
Procainamide—Nausea—Metformin—metabolic syndrome X	0.000878	0.0106	CcSEcCtD
Procainamide—SLC22A5—kidney—metabolic syndrome X	0.000759	0.022	CbGeAlD
Procainamide—BCHE—cardiovascular system—metabolic syndrome X	0.000755	0.0219	CbGeAlD
Procainamide—SLC22A1—liver—metabolic syndrome X	0.00069	0.02	CbGeAlD
Procainamide—SLC22A5—adipose tissue—metabolic syndrome X	0.000684	0.0198	CbGeAlD
Procainamide—BCHE—adipose tissue—metabolic syndrome X	0.000666	0.0193	CbGeAlD
Procainamide—SLC22A3—liver—metabolic syndrome X	0.00066	0.0191	CbGeAlD
Procainamide—CYP2D6—kidney—metabolic syndrome X	0.00049	0.0142	CbGeAlD
Procainamide—SLC22A5—liver—metabolic syndrome X	0.00048	0.0139	CbGeAlD
Procainamide—BCHE—liver—metabolic syndrome X	0.000467	0.0135	CbGeAlD
Procainamide—CYP2D6—liver—metabolic syndrome X	0.000309	0.00897	CbGeAlD
Procainamide—SLC22A2—Metabolism—PLA2G6—metabolic syndrome X	4.66e-05	0.000456	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—metabolic syndrome X	4.66e-05	0.000456	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CETP—metabolic syndrome X	4.63e-05	0.000453	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOA5—metabolic syndrome X	4.62e-05	0.000451	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GGT1—metabolic syndrome X	4.59e-05	0.000449	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GOT1—metabolic syndrome X	4.59e-05	0.000449	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HDAC3—metabolic syndrome X	4.59e-05	0.000449	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2C—metabolic syndrome X	4.56e-05	0.000446	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	4.55e-05	0.000445	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—metabolic syndrome X	4.49e-05	0.000439	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GCKR—metabolic syndrome X	4.49e-05	0.000439	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPA—metabolic syndrome X	4.49e-05	0.000439	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—metabolic syndrome X	4.48e-05	0.000438	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—metabolic syndrome X	4.48e-05	0.000438	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SCARB1—metabolic syndrome X	4.43e-05	0.000434	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	4.4e-05	0.00043	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLA2G6—metabolic syndrome X	4.35e-05	0.000425	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—AGT—metabolic syndrome X	4.34e-05	0.000424	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GHRL—metabolic syndrome X	4.32e-05	0.000423	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.32e-05	0.000422	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—metabolic syndrome X	4.32e-05	0.000422	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—metabolic syndrome X	4.32e-05	0.000422	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FMO3—metabolic syndrome X	4.32e-05	0.000422	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NAMPT—metabolic syndrome X	4.31e-05	0.000421	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SREBF1—metabolic syndrome X	4.31e-05	0.000421	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOA5—metabolic syndrome X	4.3e-05	0.000421	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—metabolic syndrome X	4.3e-05	0.00042	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TRIB3—metabolic syndrome X	4.29e-05	0.00042	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	4.28e-05	0.000419	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GCK—metabolic syndrome X	4.28e-05	0.000419	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LIPC—metabolic syndrome X	4.28e-05	0.000419	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOC3—metabolic syndrome X	4.26e-05	0.000416	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—metabolic syndrome X	4.25e-05	0.000416	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—LEP—metabolic syndrome X	4.25e-05	0.000416	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GOT2—metabolic syndrome X	4.19e-05	0.00041	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMGCR—metabolic syndrome X	4.19e-05	0.00041	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2C—metabolic syndrome X	4.14e-05	0.000405	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CETP—metabolic syndrome X	4.13e-05	0.000404	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—metabolic syndrome X	4.13e-05	0.000404	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—metabolic syndrome X	4.13e-05	0.000404	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	4.13e-05	0.000404	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	4.1e-05	0.000401	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CNR1—metabolic syndrome X	4.09e-05	0.0004	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—INS—metabolic syndrome X	4.07e-05	0.000398	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—metabolic syndrome X	4.03e-05	0.000394	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CCL2—metabolic syndrome X	4e-05	0.000392	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TRIB3—metabolic syndrome X	4e-05	0.000391	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—metabolic syndrome X	3.98e-05	0.000389	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—metabolic syndrome X	3.98e-05	0.000389	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SCARB1—metabolic syndrome X	3.96e-05	0.000387	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	3.94e-05	0.000385	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF1—metabolic syndrome X	3.94e-05	0.000385	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GHRL—metabolic syndrome X	3.92e-05	0.000384	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOB—metabolic syndrome X	3.9e-05	0.000381	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL2—metabolic syndrome X	3.87e-05	0.000378	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	3.85e-05	0.000377	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NAMPT—metabolic syndrome X	3.85e-05	0.000376	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.85e-05	0.000376	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	3.85e-05	0.000376	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	3.85e-05	0.000376	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SREBF1—metabolic syndrome X	3.84e-05	0.000376	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LIPC—metabolic syndrome X	3.82e-05	0.000374	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GCK—metabolic syndrome X	3.82e-05	0.000374	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOC3—metabolic syndrome X	3.8e-05	0.000372	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PLA2G4A—metabolic syndrome X	3.79e-05	0.000371	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.78e-05	0.000369	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—metabolic syndrome X	3.76e-05	0.000368	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GOT2—metabolic syndrome X	3.74e-05	0.000365	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMGCR—metabolic syndrome X	3.74e-05	0.000365	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCA1—metabolic syndrome X	3.73e-05	0.000365	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC2A4—metabolic syndrome X	3.73e-05	0.000365	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—LPL—metabolic syndrome X	3.72e-05	0.000364	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CNR1—metabolic syndrome X	3.72e-05	0.000363	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CETP—metabolic syndrome X	3.69e-05	0.000361	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—INS—metabolic syndrome X	3.63e-05	0.000355	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	3.62e-05	0.000354	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GGT1—metabolic syndrome X	3.62e-05	0.000353	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GOT1—metabolic syndrome X	3.62e-05	0.000353	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NAMPT—metabolic syndrome X	3.59e-05	0.000351	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—metabolic syndrome X	3.57e-05	0.000349	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GCK—metabolic syndrome X	3.56e-05	0.000349	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LIPC—metabolic syndrome X	3.56e-05	0.000349	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOC3—metabolic syndrome X	3.54e-05	0.000346	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CD36—metabolic syndrome X	3.54e-05	0.000346	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SCARB1—metabolic syndrome X	3.53e-05	0.000346	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—metabolic syndrome X	3.51e-05	0.000343	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HDAC3—metabolic syndrome X	3.51e-05	0.000343	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CETP—metabolic syndrome X	3.44e-05	0.000336	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SREBF1—metabolic syndrome X	3.43e-05	0.000335	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.37e-05	0.00033	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMGCR—metabolic syndrome X	3.34e-05	0.000326	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GOT2—metabolic syndrome X	3.34e-05	0.000326	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCA1—metabolic syndrome X	3.33e-05	0.000326	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC2A4—metabolic syndrome X	3.33e-05	0.000326	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SCARB1—metabolic syndrome X	3.29e-05	0.000322	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARA—metabolic syndrome X	3.29e-05	0.000321	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.27e-05	0.00032	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GGT1—metabolic syndrome X	3.23e-05	0.000315	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GOT1—metabolic syndrome X	3.23e-05	0.000315	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SREBF1—metabolic syndrome X	3.2e-05	0.000313	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AGT—metabolic syndrome X	3.18e-05	0.000311	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCL5—metabolic syndrome X	3.17e-05	0.00031	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MTNR1B—metabolic syndrome X	3.14e-05	0.000307	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOE—metabolic syndrome X	3.12e-05	0.000305	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMGCR—metabolic syndrome X	3.11e-05	0.000304	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT2—metabolic syndrome X	3.11e-05	0.000304	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOA1—metabolic syndrome X	3.08e-05	0.000301	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—FABP4—metabolic syndrome X	3.07e-05	0.000301	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOB—metabolic syndrome X	3.07e-05	0.0003	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRIB3—metabolic syndrome X	3.06e-05	0.000299	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RBP4—metabolic syndrome X	3.06e-05	0.000299	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.05e-05	0.000298	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—metabolic syndrome X	3.04e-05	0.000297	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PLA2G4A—metabolic syndrome X	2.98e-05	0.000292	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCA1—metabolic syndrome X	2.97e-05	0.000291	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC2A4—metabolic syndrome X	2.97e-05	0.000291	CbGpPWpGaD
Procainamide—ACHE—Metabolism—LPL—metabolic syndrome X	2.93e-05	0.000286	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	2.91e-05	0.000285	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL5—metabolic syndrome X	2.88e-05	0.000282	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GGT1—metabolic syndrome X	2.88e-05	0.000282	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GOT1—metabolic syndrome X	2.88e-05	0.000282	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.87e-05	0.000281	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—metabolic syndrome X	2.8e-05	0.000274	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CD36—metabolic syndrome X	2.78e-05	0.000272	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCA1—metabolic syndrome X	2.77e-05	0.000271	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC2A4—metabolic syndrome X	2.77e-05	0.000271	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOB—metabolic syndrome X	2.74e-05	0.000268	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—metabolic syndrome X	2.72e-05	0.000266	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOC3—metabolic syndrome X	2.71e-05	0.000265	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GGT1—metabolic syndrome X	2.68e-05	0.000263	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT1—metabolic syndrome X	2.68e-05	0.000263	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—metabolic syndrome X	2.66e-05	0.000261	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PLA2G4A—metabolic syndrome X	2.66e-05	0.00026	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGT—metabolic syndrome X	2.65e-05	0.000259	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—metabolic syndrome X	2.64e-05	0.000258	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LPL—metabolic syndrome X	2.61e-05	0.000256	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—G6PD—metabolic syndrome X	2.6e-05	0.000254	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARA—metabolic syndrome X	2.59e-05	0.000253	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	2.54e-05	0.000248	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—metabolic syndrome X	2.51e-05	0.000245	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CD36—metabolic syndrome X	2.48e-05	0.000243	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPA—metabolic syndrome X	2.48e-05	0.000242	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCKR—metabolic syndrome X	2.48e-05	0.000242	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—metabolic syndrome X	2.46e-05	0.00024	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2C—metabolic syndrome X	2.45e-05	0.000239	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOB—metabolic syndrome X	2.44e-05	0.000239	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—metabolic syndrome X	2.44e-05	0.000239	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOA1—metabolic syndrome X	2.43e-05	0.000237	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—metabolic syndrome X	2.41e-05	0.000236	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	2.4e-05	0.000235	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PLA2G4A—metabolic syndrome X	2.38e-05	0.000232	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA5—metabolic syndrome X	2.38e-05	0.000232	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CYBA—metabolic syndrome X	2.37e-05	0.000232	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—metabolic syndrome X	2.34e-05	0.000228	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—metabolic syndrome X	2.33e-05	0.000228	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—metabolic syndrome X	2.32e-05	0.000227	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARA—metabolic syndrome X	2.31e-05	0.000226	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOB—metabolic syndrome X	2.28e-05	0.000223	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—metabolic syndrome X	2.24e-05	0.000219	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CD36—metabolic syndrome X	2.22e-05	0.000217	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLA2G4A—metabolic syndrome X	2.22e-05	0.000217	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	2.21e-05	0.000216	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CNR1—metabolic syndrome X	2.2e-05	0.000215	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—metabolic syndrome X	2.19e-05	0.000214	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—metabolic syndrome X	2.18e-05	0.000213	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOA1—metabolic syndrome X	2.17e-05	0.000212	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—metabolic syndrome X	2.14e-05	0.000209	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—metabolic syndrome X	2.14e-05	0.000209	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—metabolic syndrome X	2.1e-05	0.000205	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CD36—metabolic syndrome X	2.07e-05	0.000202	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARA—metabolic syndrome X	2.06e-05	0.000202	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—metabolic syndrome X	2e-05	0.000195	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—metabolic syndrome X	1.98e-05	0.000194	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.98e-05	0.000194	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.97e-05	0.000193	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.97e-05	0.000193	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.96e-05	0.000191	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—metabolic syndrome X	1.96e-05	0.000191	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOA1—metabolic syndrome X	1.93e-05	0.000189	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—metabolic syndrome X	1.92e-05	0.000188	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARA—metabolic syndrome X	1.92e-05	0.000188	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—metabolic syndrome X	1.91e-05	0.000187	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.9e-05	0.000186	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—metabolic syndrome X	1.87e-05	0.000183	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—metabolic syndrome X	1.86e-05	0.000182	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—metabolic syndrome X	1.84e-05	0.00018	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—metabolic syndrome X	1.82e-05	0.000178	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.82e-05	0.000178	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOA1—metabolic syndrome X	1.8e-05	0.000176	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—metabolic syndrome X	1.79e-05	0.000176	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.77e-05	0.000173	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOB—metabolic syndrome X	1.74e-05	0.00017	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.72e-05	0.000168	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.72e-05	0.000168	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—metabolic syndrome X	1.72e-05	0.000168	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—metabolic syndrome X	1.7e-05	0.000167	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL5—metabolic syndrome X	1.7e-05	0.000166	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.7e-05	0.000166	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—metabolic syndrome X	1.68e-05	0.000165	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—metabolic syndrome X	1.67e-05	0.000163	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—metabolic syndrome X	1.66e-05	0.000163	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—metabolic syndrome X	1.64e-05	0.00016	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—metabolic syndrome X	1.59e-05	0.000155	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—metabolic syndrome X	1.56e-05	0.000152	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—metabolic syndrome X	1.53e-05	0.00015	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.53e-05	0.00015	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.53e-05	0.00015	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—metabolic syndrome X	1.5e-05	0.000147	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.48e-05	0.000145	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.48e-05	0.000145	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—metabolic syndrome X	1.47e-05	0.000143	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—metabolic syndrome X	1.43e-05	0.00014	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—metabolic syndrome X	1.42e-05	0.000139	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	1.39e-05	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	1.39e-05	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	0.000135	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—metabolic syndrome X	1.37e-05	0.000134	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	1.34e-05	0.000131	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.26e-05	0.000123	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—metabolic syndrome X	1.25e-05	0.000122	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	1.24e-05	0.000122	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.22e-05	0.00012	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.2e-05	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—metabolic syndrome X	1.19e-05	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	1.15e-05	0.000113	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.14e-05	0.000112	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.09e-05	0.000107	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—metabolic syndrome X	1.07e-05	0.000105	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.06e-05	0.000104	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	1.04e-05	0.000102	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.03e-05	0.000101	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.01e-05	9.85e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA1—metabolic syndrome X	9.96e-06	9.73e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.95e-06	8.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	8.81e-06	8.62e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—metabolic syndrome X	8.77e-06	8.58e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—metabolic syndrome X	8.6e-06	8.41e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—metabolic syndrome X	8.46e-06	8.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	8.13e-06	7.95e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.89e-06	7.71e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—metabolic syndrome X	7.54e-06	7.38e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—metabolic syndrome X	7.54e-06	7.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	6.91e-06	6.76e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.9e-06	6.75e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—metabolic syndrome X	6.74e-06	6.59e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—metabolic syndrome X	6.28e-06	6.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	5.21e-06	5.09e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	4.8e-06	4.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.47e-06	3.39e-05	CbGpPWpGaD
